본문 바로가기

카테고리 없음

Peripheral Nerve Injury Market Growth Analysis

Peripheral Nerve Injury Market Growth Analysis

 

Every year, around 1.35 million people die due to vehicular or road accidents. Road crashes are also the most common cause of peripheral nerve injury (PNI), affecting the brachial BP or the radial, fibular, or sciatic nerves, typically in young motorcycle riders. 

 

The Peripheral Nerve Injury incidence in 2017 in the 7MM (i.e. The United States, EU5 (the United Kingdom, Spain, Germany, Italy, and France) and Japan) was found to be 3,889,176. The Peripheral Nerve Injury incidence rate for the US was reported to be the highest in the 7MM, with over 1.5 million cases in 2017.


DelveInsight estimates an increase in the Peripheral nerve injury market from USD 2,182.82 Million in 2017 in the coming next decade owing to increasing Peripheral Nerve Injury patient pool, extensive R&D, increased funding in the domain, advances in bioengineering techniques, and a lack of approved standard of treatment for nerve repair.

 

Some of the key companies involved in developing therapies for the Peripheral nerve injury includes Neuraptive Therapeutics, Silk Biomaterials, and Orthocell Ltd.

 

For more details on Peripheral Nerve Injury Market, visit:

https://www.delveinsight.com/blog/peripheral-nerve-injury-market/